Cargando…

In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19

BACKGROUND & AIMS: Although metabolic risk factors are associated with more severe COVID-19, there is little evidence on outcomes in patients with non-alcoholic fatty liver disease (NAFLD). We here describe the clinical characteristics and outcomes of NAFLD patients in a cohort hospitalised for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forlano, Roberta, Mullish, Benjamin H., Mukherjee, Sujit K., Nathwani, Rooshi, Harlow, Cristopher, Crook, Peter, Judge, Rebekah, Soubieres, Anet, Middleton, Paul, Daunt, Anna, Perez-Guzman, Pablo, Selvapatt, Nowlan, Lemoine, Maud, Dhar, Ameet, Thursz, Mark R., Nayagam, Shevanthi, Manousou, Pinelopi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544083/ https://www.ncbi.nlm.nih.gov/pubmed/33031439 http://dx.doi.org/10.1371/journal.pone.0240400

Ejemplares similares

Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder
por: Kim, Jin Un, et al.
Publicado: (2020)

Current and future pharmacological therapies for managing cirrhosis and its complications
por: Kockerling, David, et al.
Publicado: (2019)

Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?
por: Forlano, Roberta, et al.
Publicado: (2021)

Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study
por: Perez-Guzman, Pablo N, et al.
Publicado: (2020)

Screening for NAFLD—Current Knowledge and Challenges
por: Forlano, Roberta, et al.
Publicado: (2023)

The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
por: Forlano, Roberta, et al.
Publicado: (2022)

Gut Microbiota—A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Forlano, Roberta, et al.
Publicado: (2022)

THU642 Progression To Cirrhosis And All-cause Mortality Are Increased In Postmenopausal Women With NAFLD
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Jambulingam, Nila, et al.
Publicado: (2023)

Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
por: Huang, Jian, et al.
Publicado: (2023)

Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non‐alcoholic fatty liver disease; the importance of an elevated mean platelet volume
por: Abeles, Robin D., et al.
Publicado: (2019)

High-Throughput, Machine Learning–Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease
por: Forlano, Roberta, et al.
Publicado: (2020)

Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries
por: Nayagam, Shevanthi, et al.
Publicado: (2017)

Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease
por: Daunt, Anna, et al.
Publicado: (2020)

Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia
por: Schmit, Nora, et al.
Publicado: (2023)

The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups
por: Schmit, Nora, et al.
Publicado: (2020)

A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapies
por: Selvapatt, Nowlan, et al.
Publicado: (2016)

CD8(+)T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction
por: Lebossé, Fanny, et al.
Publicado: (2019)

Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
por: Heffernan, Alastair, et al.
Publicado: (2019)

Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study
por: Middleton, Paul, et al.
Publicado: (2021)

Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination
por: Lazarus, Jeffrey V., et al.
Publicado: (2020)

Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
por: Eng, Pei Chia, et al.
Publicado: (2023)

Revisional Laparoscopic Parastomal Hernia Repair
por: Zacharakis, Emmanouil, et al.
Publicado: (2008)

Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications
por: Loktionov, Alexandre, et al.
Publicado: (2020)

The impact of the timely birth dose vaccine on the global elimination of hepatitis B
por: de Villiers, Margaret J., et al.
Publicado: (2021)

The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa
por: Lemoine, Maud, et al.
Publicado: (2016)

Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018)

Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, China
por: Heffernan, Alastair, et al.
Publicado: (2021)

Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature
por: Mullish, Benjamin H, et al.
Publicado: (2014)

Suppressor CD4(+) T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis
por: Khamri, Wafa, et al.
Publicado: (2022)

CD14(+) CD15(−) HLA-DR(−) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
por: Bernsmeier, Christine, et al.
Publicado: (2018)

1171. Impact on Mortality, Length of Stay, and Antibiotic Use in Allogenic and Autologous Stem Cell Transplant Patients Colonized With Carbapenemase-Producing Enterobacteriaceae
por: Ghani, Rohma, et al.
Publicado: (2018)

Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
por: de Villiers, Margaret J., et al.
Publicado: (2020)

Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic
por: Rao, Adya, et al.
Publicado: (2022)

HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme
por: Sow, Amina, et al.
Publicado: (2022)

The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease
por: Chambers, Edward S., et al.
Publicado: (2018)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver
por: Rashid, S. Tamir, et al.
Publicado: (2012)

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease
por: Miao, Zong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jd6niansl3vcmr2c5lmfiu3b89